NEW YORK and STOCKHOLM, Sweden, June 25, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, today announced that it has entered into a definitive agreement with Immedica Pharma AB ('Immedica'), a leading global rare disease company, for the sale of its future royalties related to sales of ganaxolone outside of China. Under the terms of the agreement, Immedica will pay $ ...

Core Viewpoint - Hut 8 Corp. has expanded its Bitcoin-backed credit facility from $65 million to up to $130 million, enhancing its capacity and lowering its cost of capital [1][2]. Group 1: Credit Facility Expansion - The amended credit facility reflects significant improvements in economic and structural terms, doubling the size of the facility and extending the maturity date to July 16, 2026 [1][2]. - The facility is expected to provide up to $65 million in incremental, non-dilutive capital, allowing the company to deploy capital against near-term growth opportunities [5]. Group 2: Financial Terms and Benefits - The conversion from a floating-rate structure to a fixed interest rate of 9.0% is designed to improve Hut 8's overall cost of capital, compared to previous rates ranging from 10.5% to 11.5% [5]. - The amended agreement includes enhanced collateral and borrower protections, such as a limited recourse structure and a no-rehypothecation covenant on pledged Bitcoin [5]. Group 3: Company Overview - Hut 8 Corp. operates as an energy infrastructure platform, integrating power, digital infrastructure, and compute at scale, primarily for Bitcoin mining and high-performance computing [3]. - The company manages 1,020 megawatts of energy capacity across 15 sites in the United States and Canada, including Bitcoin mining and high-performance computing data centers [3].